Combination of interferon (IFN) induction therapy and ribavirin in chronic hepatitis C.

被引：2
|
作者：
Ferenci, P
Brunner, H
Vogel, W
Gschwantler, M
Datz, C
Hackl, F
Steindl-Munda, PE
Hofer, H
Mueller, C
Mueller, C
机构：
[1] Univ Vienna, Vienna, Austria
[2] Hosp Lainz, Vienna, Austria
[3] Univ Innsbruck, Vienna, Austria
[4] Hosp Rudolfsstiftung, Vienna, Austria
[5] St Johann Hosp, Salzburg, Austria
[6] St Elizabeth Hosp, Linz, Austria
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)85986-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
977
引用
收藏
页码：A961 / A961
页数：1
相关论文
共 50 条
  • [21] Significance of serum ribavirin concentration in combination therapy of interferon and ribavirin for chronic hepatitis C
    Arase, Y
    Ikeda, K
    Tsubota, A
    Suzuki, F
    Suzuki, Y
    Saitoh, S
    Kobayashi, M
    Akuta, N
    Someya, T
    Hosaka, T
    Sezaki, H
    Kobayashi, M
    Kumada, H
    INTERVIROLOGY, 2005, 48 (2-3) : 138 - 144
  • [22] Comparison between IFN induction, induction plus Ribavirin and IFN plus Ribavirin combination therapy in naive patients with chronic hepatitis C related to genotype 1
    Bellobuono, A
    Tempini, S
    Idéo, GM
    Grimoldi, D
    Brasca, P
    Idéo, G
    JOURNAL OF HEPATOLOGY, 2000, 32 : 110 - 110
  • [23] Comparison of combination therapy of pegylated interferon and ribavirin with conventional interferon and ribavirin in chronic hepatitis C in Korea
    Kang, Myoung Joo
    Jung, Eun Uk
    Park, Sang Won
    Choi, Paul
    Kim, Ji Hyun
    Park, Sung Jae
    Park, Eun Taek
    Lee, Youn Jae
    Lee, Sang Hyuk
    Seol, Sang Yong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A217 - A217
  • [24] Early response to IFN induction therapy, induction plus Ribavirin and IFN plus Ribavirin combination therapy in naive patients with chronic hepatitis C related to genotype 1.
    Bellobuono, AA
    Tempini, SS
    Ideo, GMG
    Brasca, PP
    Ideo, GG
    GASTROENTEROLOGY, 2000, 118 (04) : A1425 - A1425
  • [25] High dose consensus interferon induction therapy together with ribavirin for naive patients with chronic hepatitis C.
    Fuchs, M
    Witthöft, T
    Ludwig, D
    Stange, EF
    HEPATOLOGY, 2001, 34 (04) : 579A - 579A
  • [26] αIFN and Ribavirin combination therapy reduces the occurrence of breakthrough in chronic hepatitis C
    Bellobuono, A
    Tempini, S
    Idéo, GM
    Brasca, P
    Mondazzi, L
    Antonelli, G
    Idéo, G
    JOURNAL OF HEPATOLOGY, 2000, 32 : 111 - 111
  • [27] Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C
    Davis, GL
    SEMINARS IN LIVER DISEASE, 1999, 19 : 49 - 55
  • [28] Combination therapy with ribavirin and alpha interferon for the treatment of chronic hepatitis C refractory to interferon
    Cozzolongo, R
    Cuppone, R
    Giannuzzi, V
    Amati, L
    Caradonna, L
    Tamborrino, V
    Jirillo, E
    Manghisi, OG
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (01) : 129 - 135
  • [29] Combination therapy with low dose interferon and ribavirin in naive patients with hepatitis C.
    Martin, A
    Canchis, PW
    Tamburro, CH
    Fortwengler, P
    Cecil, B
    Cox, A
    Adler, E
    Miller, B
    Chene, B
    Hiser, M
    HEPATOLOGY, 1999, 30 (04) : 620A - 620A
  • [30] Comparison between IFN induction therapy, IFN induction plus ribavirin and IFN plus ribavirin standard combination therapy in naive patients with chronic hepatitis C related to genotype 1.
    Bellocuono, AAB
    Tempini, SST
    Mondazzi, LLM
    Ideo, GMGM
    Brasca, PPB
    Bellobuono, AAB
    Ideo, GGI
    HEPATOLOGY, 2000, 32 (04) : 366A - 366A
12345